nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—MPO—Carboplatin—testicular cancer	0.242	0.302	CbGbCtD
Nabumetone—MPO—Cisplatin—testicular cancer	0.207	0.258	CbGbCtD
Nabumetone—PTGS1—Ifosfamide—testicular cancer	0.124	0.155	CbGbCtD
Nabumetone—PTGS2—Cisplatin—testicular cancer	0.0715	0.0892	CbGbCtD
Nabumetone—PTGS2—Etoposide—testicular cancer	0.0702	0.0877	CbGbCtD
Nabumetone—PTGS1—Etoposide—testicular cancer	0.0593	0.0741	CbGbCtD
Nabumetone—CYP1A2—Etoposide—testicular cancer	0.0265	0.0331	CbGbCtD
Nabumetone—Asthma—Epirubicin—testicular cancer	0.000253	0.00127	CcSEcCtD
Nabumetone—Dysphagia—Epirubicin—testicular cancer	0.000253	0.00127	CcSEcCtD
Nabumetone—Dysuria—Methotrexate—testicular cancer	0.000253	0.00127	CcSEcCtD
Nabumetone—Paraesthesia—Cisplatin—testicular cancer	0.000252	0.00126	CcSEcCtD
Nabumetone—Thrombocytopenia—Etoposide—testicular cancer	0.000252	0.00126	CcSEcCtD
Nabumetone—Liver function test abnormal—Doxorubicin—testicular cancer	0.00025	0.00126	CcSEcCtD
Nabumetone—Dyspnoea—Cisplatin—testicular cancer	0.00025	0.00125	CcSEcCtD
Nabumetone—Erectile dysfunction—Methotrexate—testicular cancer	0.000249	0.00125	CcSEcCtD
Nabumetone—Hyperhidrosis—Etoposide—testicular cancer	0.000248	0.00125	CcSEcCtD
Nabumetone—Pancreatitis—Epirubicin—testicular cancer	0.000248	0.00125	CcSEcCtD
Nabumetone—Photosensitivity reaction—Methotrexate—testicular cancer	0.000247	0.00124	CcSEcCtD
Nabumetone—Hypokalaemia—Doxorubicin—testicular cancer	0.000247	0.00124	CcSEcCtD
Nabumetone—Angina pectoris—Epirubicin—testicular cancer	0.000247	0.00124	CcSEcCtD
Nabumetone—Anorexia—Etoposide—testicular cancer	0.000245	0.00123	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000244	0.00123	CcSEcCtD
Nabumetone—Decreased appetite—Cisplatin—testicular cancer	0.000244	0.00122	CcSEcCtD
Nabumetone—Diarrhoea—Dactinomycin—testicular cancer	0.000243	0.00122	CcSEcCtD
Nabumetone—Pneumonia—Methotrexate—testicular cancer	0.000243	0.00122	CcSEcCtD
Nabumetone—Vomiting—Bleomycin—testicular cancer	0.000242	0.00121	CcSEcCtD
Nabumetone—Depression—Methotrexate—testicular cancer	0.000241	0.00121	CcSEcCtD
Nabumetone—Rash—Bleomycin—testicular cancer	0.00024	0.0012	CcSEcCtD
Nabumetone—Gastritis—Doxorubicin—testicular cancer	0.00024	0.0012	CcSEcCtD
Nabumetone—Dermatitis—Bleomycin—testicular cancer	0.00024	0.0012	CcSEcCtD
Nabumetone—Hypersensitivity—Ifosfamide—testicular cancer	0.00024	0.0012	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000239	0.0012	CcSEcCtD
Nabumetone—Renal failure—Methotrexate—testicular cancer	0.000237	0.00119	CcSEcCtD
Nabumetone—Dysuria—Epirubicin—testicular cancer	0.000237	0.00119	CcSEcCtD
Nabumetone—Stomatitis—Methotrexate—testicular cancer	0.000235	0.00118	CcSEcCtD
Nabumetone—Asthma—Doxorubicin—testicular cancer	0.000234	0.00118	CcSEcCtD
Nabumetone—Dysphagia—Doxorubicin—testicular cancer	0.000234	0.00118	CcSEcCtD
Nabumetone—Asthenia—Ifosfamide—testicular cancer	0.000233	0.00117	CcSEcCtD
Nabumetone—Photosensitivity reaction—Epirubicin—testicular cancer	0.000231	0.00116	CcSEcCtD
Nabumetone—Feeling abnormal—Cisplatin—testicular cancer	0.000231	0.00116	CcSEcCtD
Nabumetone—Paraesthesia—Etoposide—testicular cancer	0.000231	0.00116	CcSEcCtD
Nabumetone—Weight increased—Epirubicin—testicular cancer	0.000231	0.00116	CcSEcCtD
Nabumetone—Pruritus—Ifosfamide—testicular cancer	0.00023	0.00116	CcSEcCtD
Nabumetone—Haematuria—Methotrexate—testicular cancer	0.00023	0.00115	CcSEcCtD
Nabumetone—Pancreatitis—Doxorubicin—testicular cancer	0.00023	0.00115	CcSEcCtD
Nabumetone—Weight decreased—Epirubicin—testicular cancer	0.000229	0.00115	CcSEcCtD
Nabumetone—Dyspnoea—Etoposide—testicular cancer	0.000229	0.00115	CcSEcCtD
Nabumetone—Hyperglycaemia—Epirubicin—testicular cancer	0.000229	0.00115	CcSEcCtD
Nabumetone—Somnolence—Etoposide—testicular cancer	0.000228	0.00115	CcSEcCtD
Nabumetone—Angina pectoris—Doxorubicin—testicular cancer	0.000228	0.00115	CcSEcCtD
Nabumetone—Pneumonia—Epirubicin—testicular cancer	0.000227	0.00114	CcSEcCtD
Nabumetone—Nausea—Bleomycin—testicular cancer	0.000226	0.00113	CcSEcCtD
Nabumetone—Vomiting—Dactinomycin—testicular cancer	0.000226	0.00113	CcSEcCtD
Nabumetone—Agranulocytosis—Methotrexate—testicular cancer	0.000225	0.00113	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000224	0.00112	CcSEcCtD
Nabumetone—Rash—Dactinomycin—testicular cancer	0.000224	0.00112	CcSEcCtD
Nabumetone—Decreased appetite—Etoposide—testicular cancer	0.000223	0.00112	CcSEcCtD
Nabumetone—Diarrhoea—Ifosfamide—testicular cancer	0.000223	0.00112	CcSEcCtD
Nabumetone—Renal failure—Epirubicin—testicular cancer	0.000222	0.00111	CcSEcCtD
Nabumetone—Body temperature increased—Cisplatin—testicular cancer	0.000222	0.00111	CcSEcCtD
Nabumetone—Fatigue—Etoposide—testicular cancer	0.000222	0.00111	CcSEcCtD
Nabumetone—Stomatitis—Epirubicin—testicular cancer	0.00022	0.0011	CcSEcCtD
Nabumetone—Jaundice—Epirubicin—testicular cancer	0.00022	0.0011	CcSEcCtD
Nabumetone—Constipation—Etoposide—testicular cancer	0.00022	0.0011	CcSEcCtD
Nabumetone—Dysuria—Doxorubicin—testicular cancer	0.000219	0.0011	CcSEcCtD
Nabumetone—Haemoglobin—Methotrexate—testicular cancer	0.000218	0.00109	CcSEcCtD
Nabumetone—Haemorrhage—Methotrexate—testicular cancer	0.000217	0.00109	CcSEcCtD
Nabumetone—Haematuria—Epirubicin—testicular cancer	0.000215	0.00108	CcSEcCtD
Nabumetone—Dizziness—Ifosfamide—testicular cancer	0.000215	0.00108	CcSEcCtD
Nabumetone—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000214	0.00107	CcSEcCtD
Nabumetone—Weight increased—Doxorubicin—testicular cancer	0.000213	0.00107	CcSEcCtD
Nabumetone—Weight decreased—Doxorubicin—testicular cancer	0.000212	0.00106	CcSEcCtD
Nabumetone—Feeling abnormal—Etoposide—testicular cancer	0.000212	0.00106	CcSEcCtD
Nabumetone—Hyperglycaemia—Doxorubicin—testicular cancer	0.000211	0.00106	CcSEcCtD
Nabumetone—Nausea—Dactinomycin—testicular cancer	0.000211	0.00106	CcSEcCtD
Nabumetone—Agranulocytosis—Epirubicin—testicular cancer	0.000211	0.00106	CcSEcCtD
Nabumetone—Pneumonia—Doxorubicin—testicular cancer	0.00021	0.00105	CcSEcCtD
Nabumetone—Gastrointestinal pain—Etoposide—testicular cancer	0.00021	0.00105	CcSEcCtD
Nabumetone—Visual impairment—Methotrexate—testicular cancer	0.000209	0.00105	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000207	0.00104	CcSEcCtD
Nabumetone—Vomiting—Ifosfamide—testicular cancer	0.000207	0.00104	CcSEcCtD
Nabumetone—Hypersensitivity—Cisplatin—testicular cancer	0.000207	0.00104	CcSEcCtD
Nabumetone—Renal failure—Doxorubicin—testicular cancer	0.000205	0.00103	CcSEcCtD
Nabumetone—Rash—Ifosfamide—testicular cancer	0.000205	0.00103	CcSEcCtD
Nabumetone—Dermatitis—Ifosfamide—testicular cancer	0.000205	0.00103	CcSEcCtD
Nabumetone—Erythema multiforme—Methotrexate—testicular cancer	0.000205	0.00103	CcSEcCtD
Nabumetone—Urticaria—Etoposide—testicular cancer	0.000204	0.00102	CcSEcCtD
Nabumetone—Haemoglobin—Epirubicin—testicular cancer	0.000204	0.00102	CcSEcCtD
Nabumetone—Jaundice—Doxorubicin—testicular cancer	0.000204	0.00102	CcSEcCtD
Nabumetone—Stomatitis—Doxorubicin—testicular cancer	0.000204	0.00102	CcSEcCtD
Nabumetone—Body temperature increased—Etoposide—testicular cancer	0.000203	0.00102	CcSEcCtD
Nabumetone—Abdominal pain—Etoposide—testicular cancer	0.000203	0.00102	CcSEcCtD
Nabumetone—Haemorrhage—Epirubicin—testicular cancer	0.000203	0.00102	CcSEcCtD
Nabumetone—Tinnitus—Methotrexate—testicular cancer	0.000202	0.00101	CcSEcCtD
Nabumetone—Asthenia—Cisplatin—testicular cancer	0.000201	0.00101	CcSEcCtD
Nabumetone—Haematuria—Doxorubicin—testicular cancer	0.000199	0.001	CcSEcCtD
Nabumetone—Visual impairment—Epirubicin—testicular cancer	0.000195	0.000981	CcSEcCtD
Nabumetone—Agranulocytosis—Doxorubicin—testicular cancer	0.000195	0.000979	CcSEcCtD
Nabumetone—Chills—Methotrexate—testicular cancer	0.000194	0.000976	CcSEcCtD
Nabumetone—Nausea—Ifosfamide—testicular cancer	0.000193	0.00097	CcSEcCtD
Nabumetone—Diarrhoea—Cisplatin—testicular cancer	0.000192	0.000963	CcSEcCtD
Nabumetone—Erythema multiforme—Epirubicin—testicular cancer	0.000192	0.000962	CcSEcCtD
Nabumetone—Alopecia—Methotrexate—testicular cancer	0.000191	0.000961	CcSEcCtD
Nabumetone—Hypersensitivity—Etoposide—testicular cancer	0.000189	0.00095	CcSEcCtD
Nabumetone—Tinnitus—Epirubicin—testicular cancer	0.000189	0.000949	CcSEcCtD
Nabumetone—Haemoglobin—Doxorubicin—testicular cancer	0.000189	0.000946	CcSEcCtD
Nabumetone—Haemorrhage—Doxorubicin—testicular cancer	0.000188	0.000941	CcSEcCtD
Nabumetone—Asthenia—Etoposide—testicular cancer	0.000184	0.000925	CcSEcCtD
Nabumetone—Chills—Epirubicin—testicular cancer	0.000182	0.000913	CcSEcCtD
Nabumetone—Pruritus—Etoposide—testicular cancer	0.000182	0.000912	CcSEcCtD
Nabumetone—Arrhythmia—Epirubicin—testicular cancer	0.000181	0.000909	CcSEcCtD
Nabumetone—Visual impairment—Doxorubicin—testicular cancer	0.000181	0.000907	CcSEcCtD
Nabumetone—Alopecia—Epirubicin—testicular cancer	0.000179	0.000899	CcSEcCtD
Nabumetone—Vomiting—Cisplatin—testicular cancer	0.000178	0.000895	CcSEcCtD
Nabumetone—Erythema multiforme—Doxorubicin—testicular cancer	0.000177	0.00089	CcSEcCtD
Nabumetone—Rash—Cisplatin—testicular cancer	0.000177	0.000888	CcSEcCtD
Nabumetone—Dermatitis—Cisplatin—testicular cancer	0.000177	0.000887	CcSEcCtD
Nabumetone—Diarrhoea—Etoposide—testicular cancer	0.000176	0.000882	CcSEcCtD
Nabumetone—Ill-defined disorder—Methotrexate—testicular cancer	0.000175	0.000878	CcSEcCtD
Nabumetone—Tinnitus—Doxorubicin—testicular cancer	0.000175	0.000878	CcSEcCtD
Nabumetone—Anaemia—Methotrexate—testicular cancer	0.000174	0.000875	CcSEcCtD
Nabumetone—Flatulence—Epirubicin—testicular cancer	0.000174	0.000873	CcSEcCtD
Nabumetone—Tension—Epirubicin—testicular cancer	0.000173	0.000869	CcSEcCtD
Nabumetone—Nervousness—Epirubicin—testicular cancer	0.000171	0.00086	CcSEcCtD
Nabumetone—Malaise—Methotrexate—testicular cancer	0.00017	0.000854	CcSEcCtD
Nabumetone—Dizziness—Etoposide—testicular cancer	0.00017	0.000853	CcSEcCtD
Nabumetone—Vertigo—Methotrexate—testicular cancer	0.000169	0.00085	CcSEcCtD
Nabumetone—Leukopenia—Methotrexate—testicular cancer	0.000169	0.000847	CcSEcCtD
Nabumetone—Chills—Doxorubicin—testicular cancer	0.000168	0.000845	CcSEcCtD
Nabumetone—Arrhythmia—Doxorubicin—testicular cancer	0.000168	0.000841	CcSEcCtD
Nabumetone—Nausea—Cisplatin—testicular cancer	0.000167	0.000836	CcSEcCtD
Nabumetone—Alopecia—Doxorubicin—testicular cancer	0.000166	0.000832	CcSEcCtD
Nabumetone—Cough—Methotrexate—testicular cancer	0.000165	0.000826	CcSEcCtD
Nabumetone—Ill-defined disorder—Epirubicin—testicular cancer	0.000164	0.000822	CcSEcCtD
Nabumetone—Vomiting—Etoposide—testicular cancer	0.000163	0.00082	CcSEcCtD
Nabumetone—Anaemia—Epirubicin—testicular cancer	0.000163	0.000819	CcSEcCtD
Nabumetone—Agitation—Epirubicin—testicular cancer	0.000162	0.000814	CcSEcCtD
Nabumetone—Rash—Etoposide—testicular cancer	0.000162	0.000813	CcSEcCtD
Nabumetone—Dermatitis—Etoposide—testicular cancer	0.000162	0.000812	CcSEcCtD
Nabumetone—Headache—Etoposide—testicular cancer	0.000161	0.000808	CcSEcCtD
Nabumetone—Flatulence—Doxorubicin—testicular cancer	0.000161	0.000808	CcSEcCtD
Nabumetone—Tension—Doxorubicin—testicular cancer	0.00016	0.000804	CcSEcCtD
Nabumetone—Malaise—Epirubicin—testicular cancer	0.000159	0.000799	CcSEcCtD
Nabumetone—Discomfort—Methotrexate—testicular cancer	0.000159	0.000796	CcSEcCtD
Nabumetone—Nervousness—Doxorubicin—testicular cancer	0.000159	0.000796	CcSEcCtD
Nabumetone—Vertigo—Epirubicin—testicular cancer	0.000159	0.000796	CcSEcCtD
Nabumetone—Syncope—Epirubicin—testicular cancer	0.000158	0.000794	CcSEcCtD
Nabumetone—Leukopenia—Epirubicin—testicular cancer	0.000158	0.000793	CcSEcCtD
Nabumetone—Palpitations—Epirubicin—testicular cancer	0.000156	0.000783	CcSEcCtD
Nabumetone—Confusional state—Methotrexate—testicular cancer	0.000155	0.000779	CcSEcCtD
Nabumetone—Loss of consciousness—Epirubicin—testicular cancer	0.000155	0.000778	CcSEcCtD
Nabumetone—Cough—Epirubicin—testicular cancer	0.000154	0.000773	CcSEcCtD
Nabumetone—Anaphylactic shock—Methotrexate—testicular cancer	0.000154	0.000772	CcSEcCtD
Nabumetone—Nausea—Etoposide—testicular cancer	0.000153	0.000766	CcSEcCtD
Nabumetone—Hypertension—Epirubicin—testicular cancer	0.000152	0.000765	CcSEcCtD
Nabumetone—Ill-defined disorder—Doxorubicin—testicular cancer	0.000152	0.00076	CcSEcCtD
Nabumetone—Anaemia—Doxorubicin—testicular cancer	0.000151	0.000757	CcSEcCtD
Nabumetone—Thrombocytopenia—Methotrexate—testicular cancer	0.000151	0.000756	CcSEcCtD
Nabumetone—Agitation—Doxorubicin—testicular cancer	0.00015	0.000753	CcSEcCtD
Nabumetone—Anxiety—Epirubicin—testicular cancer	0.00015	0.000751	CcSEcCtD
Nabumetone—Hyperhidrosis—Methotrexate—testicular cancer	0.000149	0.000747	CcSEcCtD
Nabumetone—Discomfort—Epirubicin—testicular cancer	0.000148	0.000745	CcSEcCtD
Nabumetone—Malaise—Doxorubicin—testicular cancer	0.000147	0.000739	CcSEcCtD
Nabumetone—Dry mouth—Epirubicin—testicular cancer	0.000147	0.000737	CcSEcCtD
Nabumetone—Vertigo—Doxorubicin—testicular cancer	0.000147	0.000736	CcSEcCtD
Nabumetone—Anorexia—Methotrexate—testicular cancer	0.000147	0.000736	CcSEcCtD
Nabumetone—Syncope—Doxorubicin—testicular cancer	0.000146	0.000735	CcSEcCtD
Nabumetone—Leukopenia—Doxorubicin—testicular cancer	0.000146	0.000734	CcSEcCtD
Nabumetone—Confusional state—Epirubicin—testicular cancer	0.000145	0.000729	CcSEcCtD
Nabumetone—Palpitations—Doxorubicin—testicular cancer	0.000144	0.000724	CcSEcCtD
Nabumetone—Anaphylactic shock—Epirubicin—testicular cancer	0.000144	0.000723	CcSEcCtD
Nabumetone—Oedema—Epirubicin—testicular cancer	0.000144	0.000723	CcSEcCtD
Nabumetone—Loss of consciousness—Doxorubicin—testicular cancer	0.000144	0.00072	CcSEcCtD
Nabumetone—Cough—Doxorubicin—testicular cancer	0.000143	0.000715	CcSEcCtD
Nabumetone—Shock—Epirubicin—testicular cancer	0.000142	0.000711	CcSEcCtD
Nabumetone—Thrombocytopenia—Epirubicin—testicular cancer	0.000141	0.000708	CcSEcCtD
Nabumetone—Hypertension—Doxorubicin—testicular cancer	0.000141	0.000708	CcSEcCtD
Nabumetone—Hyperhidrosis—Epirubicin—testicular cancer	0.000139	0.000699	CcSEcCtD
Nabumetone—Insomnia—Methotrexate—testicular cancer	0.000139	0.000699	CcSEcCtD
Nabumetone—Anxiety—Doxorubicin—testicular cancer	0.000139	0.000695	CcSEcCtD
Nabumetone—Paraesthesia—Methotrexate—testicular cancer	0.000138	0.000694	CcSEcCtD
Nabumetone—Discomfort—Doxorubicin—testicular cancer	0.000137	0.000689	CcSEcCtD
Nabumetone—Anorexia—Epirubicin—testicular cancer	0.000137	0.000689	CcSEcCtD
Nabumetone—Dyspnoea—Methotrexate—testicular cancer	0.000137	0.000689	CcSEcCtD
Nabumetone—Somnolence—Methotrexate—testicular cancer	0.000137	0.000687	CcSEcCtD
Nabumetone—Dry mouth—Doxorubicin—testicular cancer	0.000136	0.000682	CcSEcCtD
Nabumetone—Dyspepsia—Methotrexate—testicular cancer	0.000135	0.00068	CcSEcCtD
Nabumetone—Confusional state—Doxorubicin—testicular cancer	0.000134	0.000674	CcSEcCtD
Nabumetone—Decreased appetite—Methotrexate—testicular cancer	0.000134	0.000671	CcSEcCtD
Nabumetone—Anaphylactic shock—Doxorubicin—testicular cancer	0.000133	0.000669	CcSEcCtD
Nabumetone—Oedema—Doxorubicin—testicular cancer	0.000133	0.000669	CcSEcCtD
Nabumetone—Fatigue—Methotrexate—testicular cancer	0.000133	0.000666	CcSEcCtD
Nabumetone—Shock—Doxorubicin—testicular cancer	0.000131	0.000658	CcSEcCtD
Nabumetone—Thrombocytopenia—Doxorubicin—testicular cancer	0.000131	0.000655	CcSEcCtD
Nabumetone—Insomnia—Epirubicin—testicular cancer	0.00013	0.000654	CcSEcCtD
Nabumetone—Paraesthesia—Epirubicin—testicular cancer	0.000129	0.000649	CcSEcCtD
Nabumetone—Hyperhidrosis—Doxorubicin—testicular cancer	0.000129	0.000647	CcSEcCtD
Nabumetone—Dyspnoea—Epirubicin—testicular cancer	0.000128	0.000644	CcSEcCtD
Nabumetone—Somnolence—Epirubicin—testicular cancer	0.000128	0.000643	CcSEcCtD
Nabumetone—Anorexia—Doxorubicin—testicular cancer	0.000127	0.000638	CcSEcCtD
Nabumetone—Feeling abnormal—Methotrexate—testicular cancer	0.000127	0.000637	CcSEcCtD
Nabumetone—Dyspepsia—Epirubicin—testicular cancer	0.000127	0.000636	CcSEcCtD
Nabumetone—Gastrointestinal pain—Methotrexate—testicular cancer	0.000126	0.000632	CcSEcCtD
Nabumetone—Decreased appetite—Epirubicin—testicular cancer	0.000125	0.000628	CcSEcCtD
Nabumetone—Fatigue—Epirubicin—testicular cancer	0.000124	0.000623	CcSEcCtD
Nabumetone—Constipation—Epirubicin—testicular cancer	0.000123	0.000618	CcSEcCtD
Nabumetone—Urticaria—Methotrexate—testicular cancer	0.000122	0.000614	CcSEcCtD
Nabumetone—Body temperature increased—Methotrexate—testicular cancer	0.000122	0.000611	CcSEcCtD
Nabumetone—Abdominal pain—Methotrexate—testicular cancer	0.000122	0.000611	CcSEcCtD
Nabumetone—Insomnia—Doxorubicin—testicular cancer	0.000121	0.000605	CcSEcCtD
Nabumetone—Paraesthesia—Doxorubicin—testicular cancer	0.00012	0.000601	CcSEcCtD
Nabumetone—Dyspnoea—Doxorubicin—testicular cancer	0.000119	0.000596	CcSEcCtD
Nabumetone—Feeling abnormal—Epirubicin—testicular cancer	0.000119	0.000596	CcSEcCtD
Nabumetone—Somnolence—Doxorubicin—testicular cancer	0.000118	0.000595	CcSEcCtD
Nabumetone—Gastrointestinal pain—Epirubicin—testicular cancer	0.000118	0.000591	CcSEcCtD
Nabumetone—Dyspepsia—Doxorubicin—testicular cancer	0.000117	0.000589	CcSEcCtD
Nabumetone—Decreased appetite—Doxorubicin—testicular cancer	0.000116	0.000581	CcSEcCtD
Nabumetone—Fatigue—Doxorubicin—testicular cancer	0.000115	0.000577	CcSEcCtD
Nabumetone—Urticaria—Epirubicin—testicular cancer	0.000114	0.000574	CcSEcCtD
Nabumetone—Constipation—Doxorubicin—testicular cancer	0.000114	0.000572	CcSEcCtD
Nabumetone—Abdominal pain—Epirubicin—testicular cancer	0.000114	0.000571	CcSEcCtD
Nabumetone—Body temperature increased—Epirubicin—testicular cancer	0.000114	0.000571	CcSEcCtD
Nabumetone—Hypersensitivity—Methotrexate—testicular cancer	0.000113	0.000569	CcSEcCtD
Nabumetone—Asthenia—Methotrexate—testicular cancer	0.00011	0.000554	CcSEcCtD
Nabumetone—Feeling abnormal—Doxorubicin—testicular cancer	0.00011	0.000551	CcSEcCtD
Nabumetone—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000109	0.000547	CcSEcCtD
Nabumetone—Pruritus—Methotrexate—testicular cancer	0.000109	0.000546	CcSEcCtD
Nabumetone—Hypersensitivity—Epirubicin—testicular cancer	0.000106	0.000533	CcSEcCtD
Nabumetone—Urticaria—Doxorubicin—testicular cancer	0.000106	0.000531	CcSEcCtD
Nabumetone—Abdominal pain—Doxorubicin—testicular cancer	0.000105	0.000529	CcSEcCtD
Nabumetone—Body temperature increased—Doxorubicin—testicular cancer	0.000105	0.000529	CcSEcCtD
Nabumetone—Diarrhoea—Methotrexate—testicular cancer	0.000105	0.000529	CcSEcCtD
Nabumetone—Asthenia—Epirubicin—testicular cancer	0.000103	0.000519	CcSEcCtD
Nabumetone—Pruritus—Epirubicin—testicular cancer	0.000102	0.000511	CcSEcCtD
Nabumetone—Dizziness—Methotrexate—testicular cancer	0.000102	0.000511	CcSEcCtD
Nabumetone—Diarrhoea—Epirubicin—testicular cancer	9.86e-05	0.000495	CcSEcCtD
Nabumetone—Hypersensitivity—Doxorubicin—testicular cancer	9.82e-05	0.000493	CcSEcCtD
Nabumetone—Vomiting—Methotrexate—testicular cancer	9.79e-05	0.000491	CcSEcCtD
Nabumetone—Rash—Methotrexate—testicular cancer	9.71e-05	0.000487	CcSEcCtD
Nabumetone—Dermatitis—Methotrexate—testicular cancer	9.7e-05	0.000487	CcSEcCtD
Nabumetone—Headache—Methotrexate—testicular cancer	9.64e-05	0.000484	CcSEcCtD
Nabumetone—Asthenia—Doxorubicin—testicular cancer	9.56e-05	0.00048	CcSEcCtD
Nabumetone—Dizziness—Epirubicin—testicular cancer	9.53e-05	0.000478	CcSEcCtD
Nabumetone—Pruritus—Doxorubicin—testicular cancer	9.43e-05	0.000473	CcSEcCtD
Nabumetone—Vomiting—Epirubicin—testicular cancer	9.16e-05	0.00046	CcSEcCtD
Nabumetone—Nausea—Methotrexate—testicular cancer	9.14e-05	0.000459	CcSEcCtD
Nabumetone—Diarrhoea—Doxorubicin—testicular cancer	9.12e-05	0.000458	CcSEcCtD
Nabumetone—Rash—Epirubicin—testicular cancer	9.08e-05	0.000456	CcSEcCtD
Nabumetone—Dermatitis—Epirubicin—testicular cancer	9.07e-05	0.000455	CcSEcCtD
Nabumetone—Headache—Epirubicin—testicular cancer	9.02e-05	0.000453	CcSEcCtD
Nabumetone—Dizziness—Doxorubicin—testicular cancer	8.81e-05	0.000442	CcSEcCtD
Nabumetone—Nausea—Epirubicin—testicular cancer	8.56e-05	0.000429	CcSEcCtD
Nabumetone—Vomiting—Doxorubicin—testicular cancer	8.47e-05	0.000425	CcSEcCtD
Nabumetone—Rash—Doxorubicin—testicular cancer	8.4e-05	0.000422	CcSEcCtD
Nabumetone—Dermatitis—Doxorubicin—testicular cancer	8.4e-05	0.000421	CcSEcCtD
Nabumetone—Headache—Doxorubicin—testicular cancer	8.35e-05	0.000419	CcSEcCtD
Nabumetone—Nausea—Doxorubicin—testicular cancer	7.92e-05	0.000397	CcSEcCtD
